77 related articles for article (PubMed ID: 18669503)
61. Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model.
Wojcik S; Nogalska A; McFerrin J; Engel WK; Oledzka G; Askanas V
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):238-42. PubMed ID: 17359364
[No Abstract] [Full Text] [Related]
62. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
[TBL] [Abstract][Full Text] [Related]
63. Sporadic inclusion body myositis: a continuing puzzle.
Needham M; Mastaglia FL
Neuromuscul Disord; 2008 Jan; 18(1):6-16. PubMed ID: 18160291
[TBL] [Abstract][Full Text] [Related]
64. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 2007 Nov; 19(6):550-9. PubMed ID: 17917534
[TBL] [Abstract][Full Text] [Related]
65. Fourteen newly recognized proteins at the human neuromuscular junctions--and their nonjunctional accumulation in inclusion-body myositis.
Askanas V; Engel WK; Alvarez RB
Ann N Y Acad Sci; 1998 May; 841():28-56. PubMed ID: 9668220
[No Abstract] [Full Text] [Related]
66. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
Zetterberg H
Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
[TBL] [Abstract][Full Text] [Related]
67. Comment on 'Interrelation of inflammation and APP in sIBM: IL-1beta induces accumulation of beta-amyloid in skeletal muscle'.
Greenberg SA
Brain; 2009 Apr; 132(Pt 4):e106; author reply e107. PubMed ID: 18669503
[No Abstract] [Full Text] [Related]
68. A perspective on sporadic inclusion-body myositis: the role of aging and inflammatory processes.
Finch CE
Neurology; 2006 Jan; 66(2 Suppl 1):S1-6. PubMed ID: 16432135
[TBL] [Abstract][Full Text] [Related]
69. Inclusion body myositis: new insights into pathogenesis.
Garlepp MJ; Mastaglia FL
Curr Opin Rheumatol; 2008 Nov; 20(6):662-8. PubMed ID: 18946325
[TBL] [Abstract][Full Text] [Related]
70. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
71. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
Askanas V; Engel WK
Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
[TBL] [Abstract][Full Text] [Related]
72. Treatment and prevention of the amyloidoses: can the lessons learned be applied to sporadic inclusion-body myositis?
Buxbaum JN
Neurology; 2006 Jan; 66(2 Suppl 1):S110-3. PubMed ID: 16432137
[TBL] [Abstract][Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
